Weighted-Average Shares Outstanding (Diluted): The number of shares held by shareholders including insiders but not including a company's treasury shares assuming conversion of all convertible debt, securities, warrants and options, sourced from the company 10-K or 10-Q SEC reports.
Vigil Neuroscience, Inc. (VIGL) had Weighted-Average Shares Outstanding (Diluted) of 46.07M for the most recently reported fiscal quarter, ending 2025-03-31.
| Income Statement Financials | |
-- |
|
$-22.41M |
|
-- |
|
-- |
|
$23.47M |
|
$-23.47M |
|
$1.06M |
|
$-22.41M |
|
$-22.41M |
|
$-22.41M |
|
$-22.41M |
|
$-22.41M |
|
$-22.41M |
|
$-23.47M |
|
$-23.57M |
|
46.07M |
|
|
Weighted-Average Shares Outstanding (Diluted) |
46.07M |
$-0.49 |
|
$-0.49 |
|
| Balance Sheet Financials | |
$90.15M |
|
$1.53M |
|
$17.00M |
|
$107.15M |
|
$30.40M |
|
-- |
|
$11.62M |
|
$42.02M |
|
$65.12M |
|
$65.12M |
|
$65.12M |
|
46.67M |
|
| Cash Flow Statement Financials | |
$-23.89M |
|
$23.23M |
|
$13.27M |
|
$39.95M |
|
$52.55M |
|
$12.60M |
|
$2.64M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
2.97 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-24.18M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-34.42% |
|
-34.42% |
|
-20.92% |
|
-34.42% |
|
$1.40 |
|
$-0.52 |
|
$-0.52 |
|